Osteoboost Health Raises $8 Million

Osteoboost Health, a Redwood City-based company specializing in wearable therapies for osteopenia, has announced an $8 million financing round. The innovative company offers the first and only FDA-cleared wearable device designed to reduce bone loss in the spine, available via prescription.

Funding Details

The funding round was led by Ambit Health Ventures, with participation from Emmeline Ventures, Disrupt Health Impact Fund, Esplanade Ventures, and Portfolia. Although the specific stage of the funding round was not disclosed, the capital injection is set to boost Osteoboost Health's operations significantly.

Leadership and Vision

Osteoboost Health is helmed by CEO Laura Yecies and Chief Scientific Officer and Co-Founder Michael Jaasma. The company aims to provide science-driven solutions to improve health outcomes for individuals at risk of osteoporosis and bone fractures. "Our focus is on making a tangible difference in the lives of those affected by low bone density," said Yecies.

Strategic Use of Funds

The newly acquired funds will be allocated towards scaling up manufacturing capabilities, expanding clinical research, and broadening the commercial reach of Osteoboost's FDA-approved device. This strategic expansion aims to establish the device as a new standard of care for treating postmenopausal osteopenia.

About the Device

Osteoboost's wearable therapy provides a non-invasive option for individuals with osteopenia, a condition characterized by lower than average bone density. The device is clinically proven to help mitigate bone loss, particularly in the spine, offering a promising alternative to traditional treatment methods.

Investor Confidence

The involvement of prominent investors such as Ambit Health Ventures and others underscores the confidence in Osteoboost Health's potential to impact the healthcare market. The funding not only supports the company's immediate goals but also positions it for future growth as it seeks to address a significant health concern affecting millions worldwide.

For more information about Osteoboost Health and their innovative solutions, visit their website.